Clinical Trials

Biography

Biography: Brian M Toglia

Abstract

A key component of international clinical trials that is often overlooked is insurance considerations for the country where the study will be performed. Failure to comply with jurisdictional or IRB insurance requirements can delay approval for the start of a trial. In drug development, any delay could cost the sponsor millions of dollars. Having the proper insurance program structure is also critical to avoid any gaps in protection.  Working with a qualified insurance broker that has key relationship with global insurance companies is critical.  A proactive approach and understanding of the parameters of insurance procurement for global clinical trial will produce a well managed clinical trials insurance process as it relates to efficiency, affordability, protection and ease of administration.